Retirement Systems Of Alabama Bluebird Bio, Inc. Transaction History

Retirement Systems Of Alabama

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$59.47 - $93.1 $1.43 Million - $2.24 Million	-24,100 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$64.44 - $104.11 $128,880 - $208,220	2,000 Added 9.05%	24,100 $3.79 Million
Q4 2018 Jan 10, 2019	BUY	$59.1 - $93.26 $236,400 - $373,040	4,000 Added 22.1%	22,100 $2.19 Million
Q2 2018 Jul 17, 2018	BUY	$99.64 - $127.59 $1.8 Million - $2.31 Million	18,100 New	18,100 $2.84 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

Stay updated on Retirement Systems Of Alabama with notifications on news.